BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

SYGNIS Pharma AG 

Postfach 103780

Heidelberg    69027  Germany
Phone: 49-0-6221-4038-0 Fax: 49-0-6221-4038-101


SEARCH JOBS




Industry
Pharmaceutical






 Company News
SYGNIS Pharma AG Presents Its First Own Product Line Based On PrimPol Technology: TruePrime 11/20/2014 11:15:32 AM
SYGNIS Pharma AG Release: GBC Research Reiterates “BUY” Recommendation For SYGNIS Shares With Price Target Of €4.05 11/19/2014 1:33:08 PM
SYGNIS Pharma AG’ New TthPrimPol Polymerase Took Centre Stage At Zing DNA Polymerases Conference 2014 9/22/2014 12:37:25 PM
SYGNIS Pharma AG Reports Half-Year Results For The Period Ended June 30, 2014 8/14/2014 2:08:05 PM
GBC Research Reiterates "BUY" Recommendation On SYGNIS Pharma AG With A Price Target Of EUR6.00 4/16/2014 10:01:01 AM
First SYGNIS Pharma AG QualiPhi® -Based Products Launched By QIAGEN Inc. (QGEN) 2/12/2014 1:36:29 PM
SYGNIS Pharma AG Capital Increase Oversubscribed At Final Closing 12/18/2013 1:31:50 PM
SYGNIS Pharma AG Secures Further Financial Resources With New Investors Loan 7/8/2013 9:29:55 AM
SYGNIS Pharma AG Announces Management Board Changes 3/26/2013 9:44:54 AM
SYGNIS Pharma AG to Discontinue Ongoing R&D Project, Trim Workforce 12/20/2012 6:40:05 AM
123456